Literature DB >> 32604207

Diagnosing Calciphylaxis: A Review With Emphasis on Histopathology.

Eman Bahrani1, Ifeoma U Perkins2, Jeffrey P North3.   

Abstract

Calciphylaxis is a cutaneous vasculopathy with high morbidity and mortality characterized by vascular intimal fibrosis, calcification, stenosis, thrombosis, and eventual tissue death due to ischemia. Histopathologic diagnosis is often difficult, frequently necessitating multiple tissues samples due to lack of specific histopathologic features and subtle changes on biopsies of early lesions. In this study, we review the reported clinical and histopathologic features of calciphylaxis, correlating them with relevant imaging, ancillary studies, and pathophysiology. Although many histopathologic changes seen in calciphylaxis are also reported in other conditions (eg, Mönckeberg sclerosis, lupus panniculitis, pancreatic panniculitis, and peripheral artery disease), calcification of subcutaneous small vessels, thrombosis and/or ischemic changes, pseudoxanthoma elasticum-like changes in the subcutis, and perieccrine calcification may serve as helpful clues. von Kossa and Alizarin red stains can assist in the identification of subtle calcification. Netlike calcification of the affected blood vessels on imaging further supports the diagnosis. Studies into the pathophysiology of calciphylaxis are ongoing and will hopefully facilitate the development of additional diagnostic adjuncts to increase sensitivity and specificity for the diagnosis of this disease.

Entities:  

Mesh:

Year:  2020        PMID: 32604207     DOI: 10.1097/DAD.0000000000001526

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  4 in total

1.  Prevalence and Clinical Characteristics of Calciphylaxis in Chinese Hemodialysis Patients.

Authors:  Yuqiu Liu; Canlin Yang; Xin Yang; Xiaotong Xie; Hong Liu; Liuping Zhang; Jianming Ye; Dongsheng Jiang; Xiaoliang Zhang; Bicheng Liu
Journal:  Front Med (Lausanne)       Date:  2022-06-10

2.  Risk factors for calciphylaxis in Chinese hemodialysis patients: a matched case-control study.

Authors:  Yuqiu Liu; Xiaoliang Zhang; Xiaotong Xie; Xin Yang; Hong Liu; Rining Tang; Bicheng Liu
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

3.  The CALCIPHYX study: a randomized, double-blind, placebo-controlled, Phase 3 clinical trial of SNF472 for the treatment of calciphylaxis.

Authors:  Smeeta Sinha; Lisa J Gould; Sagar U Nigwekar; Thomas E Serena; Vincent Brandenburg; Sharon M Moe; George Aronoff; Dinesh K Chatoth; Jeffrey L Hymes; Stephan Miller; Claire Padgett; Kevin J Carroll; Joan Perelló; Alex Gold; Glenn M Chertow
Journal:  Clin Kidney J       Date:  2021-07-06

4.  Case Report: Idiopathic Subcutaneous Thrombotic Vasculopathy.

Authors:  Kerilyn Godbe; Ashlie Elver; Peter Chow; Chris Williams; Garth Fraga; Penelope Harris; Mohammed Taha; Dhaval Bhavsar; Richard Korentager
Journal:  Front Med (Lausanne)       Date:  2022-04-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.